ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
about
Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.Von Willebrand factor protects against acute CCl4-induced hepatotoxicity through phospho-p38 MAPK signaling pathway inhibition.Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma.Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis.
P2860
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
ADAMTS-13 and von Willebrand f ...... olism in patients with cancer.
@en
ADAMTS-13 and von Willebrand f ...... olism in patients with cancer.
@nl
type
label
ADAMTS-13 and von Willebrand f ...... olism in patients with cancer.
@en
ADAMTS-13 and von Willebrand f ...... olism in patients with cancer.
@nl
prefLabel
ADAMTS-13 and von Willebrand f ...... olism in patients with cancer.
@en
ADAMTS-13 and von Willebrand f ...... olism in patients with cancer.
@nl
P2093
P2860
P356
P1476
ADAMTS-13 and von Willebrand f ...... olism in patients with cancer.
@en
P2093
A Kleinjan
A Stepanian
A Veyradier
H R Büller
M Di Nisio
P W Kamphuisen
P2860
P304
P356
10.1111/JTH.13205
P50
P577
2016-01-25T00:00:00Z